JP2022500441A5 - - Google Patents
Info
- Publication number
- JP2022500441A5 JP2022500441A5 JP2021514123A JP2021514123A JP2022500441A5 JP 2022500441 A5 JP2022500441 A5 JP 2022500441A5 JP 2021514123 A JP2021514123 A JP 2021514123A JP 2021514123 A JP2021514123 A JP 2021514123A JP 2022500441 A5 JP2022500441 A5 JP 2022500441A5
- Authority
- JP
- Japan
- Prior art keywords
- crystal morphology
- crystalline form
- degrees
- diffraction pattern
- ray powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862731014P | 2018-09-13 | 2018-09-13 | |
| US62/731,014 | 2018-09-13 | ||
| PCT/US2019/050771 WO2020056105A1 (en) | 2018-09-13 | 2019-09-12 | Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl) piperazine-1-carboxylate, compositions and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022500441A JP2022500441A (ja) | 2022-01-04 |
| JP2022500441A5 true JP2022500441A5 (enExample) | 2022-08-12 |
| JP7405840B2 JP7405840B2 (ja) | 2023-12-26 |
Family
ID=68069873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021514123A Active JP7405840B2 (ja) | 2018-09-13 | 2019-09-12 | 結晶性（ｒ）－５－カルバモイルピリジン－３－イル－２－メチル－４－（３－（トリフルオロメトキシ）ベンジル）ピペラジン－１－カルボキシレート、組成物、及びその使用方法 |
Country Status (28)
| Country | Link |
|---|---|
| US (4) | US11053199B2 (enExample) |
| EP (2) | EP4434583B1 (enExample) |
| JP (1) | JP7405840B2 (enExample) |
| KR (1) | KR102844245B1 (enExample) |
| CN (3) | CN118561814A (enExample) |
| AU (1) | AU2019337623B2 (enExample) |
| BR (1) | BR112021004340A2 (enExample) |
| CA (1) | CA3112200A1 (enExample) |
| CL (1) | CL2021000596A1 (enExample) |
| CO (1) | CO2021003295A2 (enExample) |
| DK (1) | DK3849970T3 (enExample) |
| EA (1) | EA202190511A1 (enExample) |
| ES (1) | ES2993173T3 (enExample) |
| FI (1) | FI3849970T3 (enExample) |
| HR (1) | HRP20241294T1 (enExample) |
| HU (1) | HUE068147T2 (enExample) |
| IL (1) | IL281276B2 (enExample) |
| LT (1) | LT3849970T (enExample) |
| MA (1) | MA53607B1 (enExample) |
| MX (1) | MX2021002923A (enExample) |
| MY (2) | MY210363A (enExample) |
| PL (1) | PL3849970T3 (enExample) |
| PT (1) | PT3849970T (enExample) |
| RS (1) | RS65967B1 (enExample) |
| SG (1) | SG11202102143RA (enExample) |
| SI (1) | SI3849970T1 (enExample) |
| SM (1) | SMT202400369T1 (enExample) |
| WO (1) | WO2020056105A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019337623B2 (en) | 2018-09-13 | 2024-12-05 | Celgene Corporation | Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl) piperazine-1- carboxylate, compositions and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI385164B (zh) | 2005-02-17 | 2013-02-11 | Astellas Pharma Inc | Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivatives (II) |
| EP3099332A4 (en) * | 2014-01-29 | 2017-06-21 | Madrigal Pharmaceuticals, Inc. | Targeted therapeutics |
| EP4335848A3 (en) | 2017-03-13 | 2024-06-19 | Lundbeck La Jolla Research Center, Inc. | Dual magl and faah inhibitors |
| AU2019337623B2 (en) | 2018-09-13 | 2024-12-05 | Celgene Corporation | Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl) piperazine-1- carboxylate, compositions and methods of use thereof |
-
2019
- 2019-09-12 AU AU2019337623A patent/AU2019337623B2/en active Active
- 2019-09-12 MY MYPI2024007477A patent/MY210363A/en unknown
- 2019-09-12 CA CA3112200A patent/CA3112200A1/en active Pending
- 2019-09-12 CN CN202410683425.0A patent/CN118561814A/zh active Pending
- 2019-09-12 DK DK19778721.1T patent/DK3849970T3/da active
- 2019-09-12 JP JP2021514123A patent/JP7405840B2/ja active Active
- 2019-09-12 PT PT197787211T patent/PT3849970T/pt unknown
- 2019-09-12 MX MX2021002923A patent/MX2021002923A/es unknown
- 2019-09-12 MY MYPI2021001295A patent/MY208901A/en unknown
- 2019-09-12 EA EA202190511A patent/EA202190511A1/ru unknown
- 2019-09-12 SI SI201930824T patent/SI3849970T1/sl unknown
- 2019-09-12 KR KR1020217010747A patent/KR102844245B1/ko active Active
- 2019-09-12 US US16/569,578 patent/US11053199B2/en active Active
- 2019-09-12 HU HUE19778721A patent/HUE068147T2/hu unknown
- 2019-09-12 LT LTEPPCT/US2019/050771T patent/LT3849970T/lt unknown
- 2019-09-12 SG SG11202102143RA patent/SG11202102143RA/en unknown
- 2019-09-12 PL PL19778721.1T patent/PL3849970T3/pl unknown
- 2019-09-12 CN CN202410683444.3A patent/CN118530218A/zh active Pending
- 2019-09-12 FI FIEP19778721.1T patent/FI3849970T3/fi active
- 2019-09-12 HR HRP20241294TT patent/HRP20241294T1/hr unknown
- 2019-09-12 CN CN201980060119.9A patent/CN113227069B/zh active Active
- 2019-09-12 MA MA53607A patent/MA53607B1/fr unknown
- 2019-09-12 RS RS20241039A patent/RS65967B1/sr unknown
- 2019-09-12 BR BR112021004340-3A patent/BR112021004340A2/pt unknown
- 2019-09-12 SM SM20240369T patent/SMT202400369T1/it unknown
- 2019-09-12 WO PCT/US2019/050771 patent/WO2020056105A1/en not_active Ceased
- 2019-09-12 IL IL281276A patent/IL281276B2/en unknown
- 2019-09-12 EP EP24185102.1A patent/EP4434583B1/en active Active
- 2019-09-12 EP EP19778721.1A patent/EP3849970B1/en active Active
- 2019-09-12 ES ES19778721T patent/ES2993173T3/es active Active
-
2021
- 2021-03-10 CL CL2021000596A patent/CL2021000596A1/es unknown
- 2021-03-12 CO CONC2021/0003295A patent/CO2021003295A2/es unknown
- 2021-06-03 US US17/338,182 patent/US11680046B2/en active Active
-
2023
- 2023-05-05 US US18/143,765 patent/US12410133B2/en active Active
-
2025
- 2025-08-06 US US19/292,473 patent/US20260062384A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022512399A5 (enExample) | ||
| JP2024026550A5 (enExample) | ||
| JP2023116503A5 (enExample) | ||
| JP2022183220A5 (enExample) | ||
| JPWO2022138987A5 (enExample) | ||
| JP2011513485A5 (enExample) | ||
| JP2023519891A5 (enExample) | ||
| JP2010514806A5 (enExample) | ||
| JP2010539237A5 (enExample) | ||
| JP2022507251A5 (enExample) | ||
| JP2022543155A5 (enExample) | ||
| JP2015516968A5 (enExample) | ||
| JP2020521732A5 (enExample) | ||
| JP2023528565A (ja) | Ｇｌｐ－１受容体アゴニストの結晶形ａおよびその調製法 | |
| JP2012500819A5 (enExample) | ||
| JP2022523368A5 (enExample) | ||
| JP2024530164A5 (enExample) | ||
| HU228423B1 (en) | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis | |
| JP2024505063A5 (enExample) | ||
| JP2022500441A5 (enExample) | ||
| US20210130333A1 (en) | Crystal of benzofuran derivative free base and preparation method | |
| JP2017210488A5 (enExample) | ||
| WO2018019084A1 (zh) | 一种苯甲酰胺类化合物及其在制备抑制癌细胞增殖和/或治疗癌症的药物中的应用 | |
| CN103724307A (zh) | 含笑内酯二甲基胺富马酸盐的晶型及制备方法 | |
| JP2022534788A5 (enExample) |